• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三种新型 SLC37A4 变异体与 1b 型糖原贮积症:文献综述

Three novel SLC37A4 variants in glycogen storage disease type 1b and a literature review.

机构信息

Department of Gastroenterology, Hebei Children's Hospital, 133 Jianhua South Street, Shijiazhuang 050031, Hebei Province, China.

Department of Neonatology, Hebei Children's Hospital, 133 Jianhua South Street, Shijiazhuang 050031, Hebei Province, China.

出版信息

J Int Med Res. 2023 Dec;51(12):3000605231216633. doi: 10.1177/03000605231216633.

DOI:10.1177/03000605231216633
PMID:38087503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10718061/
Abstract

Glycogen storage disease type 1b (GSD1b) is a rare genetic disorder, resulting from mutations in the SLC37A4 gene located on chromosome 11q23.3. Although the SLC37A4 gene has been identified as the pathogenic gene for GSD1b, the complete variant spectrum of this gene remains to be fully elucidated. In this study, we present three patients diagnosed with GSD1b through genetic testing. We detected five variants of the SLC37A4 gene in these three patients, with three of these mutations (p. L382Pfs15, p. G117fs28, and p. T312Sfs*13) being novel variants not previously reported in the literature. We also present a literature review and general overview of the currently reported SLC37A4 gene variants. Our study expands the mutation spectrum of SLC37A4, which may help enable genetic testing to facilitate prompt diagnosis, appropriate intervention, and genetic counseling for affected families.

摘要

糖原贮积病 1b 型(GSD1b)是一种罕见的遗传性疾病,由位于 11q23.3 染色体上的 SLC37A4 基因突变引起。虽然 SLC37A4 基因已被确定为 GSD1b 的致病基因,但该基因的完整变异谱仍有待充分阐明。在本研究中,我们通过基因检测诊断了 3 名 GSD1b 患者。在这 3 名患者中检测到了 SLC37A4 基因的 5 种变异,其中 3 种突变(p. L382Pfs15、p. G117fs28 和 p. T312Sfs*13)为文献中未报道过的新变异。我们还对目前报道的 SLC37A4 基因突变进行了文献回顾和综述。我们的研究扩展了 SLC37A4 的突变谱,这可能有助于基因检测,从而为受影响的家庭提供及时的诊断、适当的干预和遗传咨询。

相似文献

1
Three novel SLC37A4 variants in glycogen storage disease type 1b and a literature review.三种新型 SLC37A4 变异体与 1b 型糖原贮积症:文献综述
J Int Med Res. 2023 Dec;51(12):3000605231216633. doi: 10.1177/03000605231216633.
2
Novel SLC37A4 Mutations in Korean Patients With Glycogen Storage Disease Ib.韩国糖原贮积病Ib型患者中的新型SLC37A4突变
Ann Lab Med. 2017 May;37(3):261-266. doi: 10.3343/alm.2017.37.3.261.
3
Co-inheritance of the membrane frizzled-related protein ocular phenotype and glycogen storage disease type Ib.膜卷曲相关蛋白眼部表型与Ib型糖原贮积病的共同遗传。
Ophthalmic Genet. 2017 Dec;38(6):544-548. doi: 10.1080/13816810.2017.1323340. Epub 2017 May 16.
4
Genotype-phenotype correlation and description of two novel mutations in Iranian patients with glycogen storage disease 1b (GSD1b).基因型-表型相关性及伊朗糖原贮积病 1b 型(GSD1b)患者两种新型突变的描述。
Orphanet J Rare Dis. 2020 Jan 31;15(1):35. doi: 10.1186/s13023-019-1266-3.
5
[Mutation in the SLC37A4 gene of glycogen storage disease type Ib in 15 families of the mainland of China].[中国大陆15个家庭中I型糖原贮积病的SLC37A4基因突变]
Zhonghua Er Ke Za Zhi. 2011 Mar;49(3):203-8.
6
Novel mutation of SLC37A4 in a glycogen storage disease type Ib patient with neutropenia, horseshoe kidney, and arteriovenous malformation: a case report.糖原贮积病Ib型合并中性粒细胞减少、马蹄肾和动静脉畸形患者的SLC37A4基因新突变:病例报告
Immunol Res. 2023 Feb;71(1):107-111. doi: 10.1007/s12026-022-09320-w. Epub 2022 Sep 21.
7
Genetic characterization of GSD I in Serbian population revealed unexpectedly high incidence of GSD Ib and 3 novel SLC37A4 variants.对塞尔维亚人群中 GSD I 的遗传特征进行分析,结果出人意料地发现 GSD Ib 发病率较高,以及 3 种新型 SLC37A4 变异体。
Clin Genet. 2018 Feb;93(2):350-355. doi: 10.1111/cge.13093. Epub 2017 Dec 11.
8
[Gene mutations and clinical manifestations in children with glycogen storage disease type Ib].[1b型糖原贮积病患儿的基因突变与临床表现]
Zhongguo Dang Dai Er Ke Za Zhi. 2013 Aug;15(8):661-5.
9
CRISPR/Cas9 genome editing of SLC37A4 gene elucidates the role of molecular markers of endoplasmic reticulum stress and apoptosis in renal involvement in glycogen storage disease type Ib.CRISPR/Cas9 基因编辑 SLC37A4 基因阐明了内质网应激和细胞凋亡的分子标志物在糖原贮积病 Ib 型肾受累中的作用。
Gene. 2019 Jun 30;703:17-25. doi: 10.1016/j.gene.2019.04.002. Epub 2019 Apr 3.
10
Mutation analysis of in a patient with glycogen storage disease-type Ib.一名糖原贮积病 Ib 型患者的[具体基因或其他相关内容]突变分析 。 (原文此处“of”后面缺少具体所指内容)
J Int Med Res. 2019 Dec;47(12):5996-6003. doi: 10.1177/0300060519867819. Epub 2019 Oct 16.

引用本文的文献

1
Copper Pyrithione Induces Hepatopancreatic Apoptosis and Metabolic Disruption in : Integrated Transcriptomic, Metabolomic, and Histopathological Analysis.巯氧吡啶铜诱导肝胰腺细胞凋亡和代谢紊乱:整合转录组学、代谢组学和组织病理学分析
Animals (Basel). 2025 Jul 18;15(14):2134. doi: 10.3390/ani15142134.
2
Empagliflozin in children with glycogen storage disease-associated inflammatory bowel disease: a prospective, single-arm, open-label clinical trial.依帕格列净治疗糖原贮积病相关炎症性肠病患儿的前瞻性、单臂、开放标签临床试验。
Sci Rep. 2024 Apr 15;14(1):8630. doi: 10.1038/s41598-024-59320-z.

本文引用的文献

1
Treatment of the Neutropenia Associated with GSD1b and G6PC3 Deficiency with SGLT2 Inhibitors.用钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂治疗与糖原贮积病1b型(GSD1b)和葡萄糖-6-磷酸酶催化亚基3(G6PC3)缺乏相关的中性粒细胞减少症。
Diagnostics (Basel). 2023 May 19;13(10):1803. doi: 10.3390/diagnostics13101803.
2
Intestinal stricture in a patient with glycogen storage disease type Ib and inflammatory bowel disease.
Asian J Surg. 2022 Nov;45(11):2437-2438. doi: 10.1016/j.asjsur.2022.05.089. Epub 2022 Jun 13.
3
Novel mutation of SLC37A4 in a glycogen storage disease type Ib patient with neutropenia, horseshoe kidney, and arteriovenous malformation: a case report.糖原贮积病Ib型合并中性粒细胞减少、马蹄肾和动静脉畸形患者的SLC37A4基因新突变:病例报告
Immunol Res. 2023 Feb;71(1):107-111. doi: 10.1007/s12026-022-09320-w. Epub 2022 Sep 21.
4
Efficacy and safety of empagliflozin in glycogen storage disease type Ib: Data from an international questionnaire.依帕列净治疗 1b 型糖原贮积症的疗效和安全性:国际问卷调查数据。
Genet Med. 2022 Aug;24(8):1781-1788. doi: 10.1016/j.gim.2022.04.001. Epub 2022 May 3.
5
A Novel Lipoprotein Lipase Mutation in an Infant With Glycogen Storage Disease Type-Ib and Severe Hypertriglyceridemia.一名患有I型糖原贮积病和严重高甘油三酯血症婴儿的新型脂蛋白脂肪酶突变
Front Pediatr. 2021 Aug 17;9:671536. doi: 10.3389/fped.2021.671536. eCollection 2021.
6
Empagliflozin ameliorated neutropenia in a girl with glycogen storage disease Ib.恩格列净改善了一名患有糖原贮积病Ib型女孩的中性粒细胞减少症。
Pediatr Int. 2021 Nov;63(11):1394-1396. doi: 10.1111/ped.14629. Epub 2021 Aug 11.
7
The natural history of glycogen storage disease type Ib in England: A multisite survey.英格兰1b型糖原贮积病的自然病史:一项多中心调查。
JIMD Rep. 2021 Jan 24;59(1):52-59. doi: 10.1002/jmd2.12200. eCollection 2021 May.
8
Clinical and genetic spectrum of glycogen storage disease in Iranian population using targeted gene sequencing.应用靶向基因测序分析伊朗人群糖原贮积症的临床和遗传学特征。
Sci Rep. 2021 Mar 29;11(1):7040. doi: 10.1038/s41598-021-86338-4.
9
Clinical analysis and long-term treatment monitoring of 3 patients with glycogen storage disease type Ib.3 例糖原贮积病 Ib 型的临床分析及长期治疗监测
BMC Med Genomics. 2021 Mar 17;14(1):81. doi: 10.1186/s12920-021-00936-9.
10
Novel variants in Turkish patients with glycogen storage disease.土耳其糖原贮积病患者中的新型变异体。
Pediatr Int. 2020 Oct;62(10):1145-1150. doi: 10.1111/ped.14286. Epub 2020 Sep 28.